ATE437955T1 - Modulation der produktion von kapsel- polysacchariden aus pneumokokken - Google Patents

Modulation der produktion von kapsel- polysacchariden aus pneumokokken

Info

Publication number
ATE437955T1
ATE437955T1 AT01918754T AT01918754T ATE437955T1 AT E437955 T1 ATE437955 T1 AT E437955T1 AT 01918754 T AT01918754 T AT 01918754T AT 01918754 T AT01918754 T AT 01918754T AT E437955 T1 ATE437955 T1 AT E437955T1
Authority
AT
Austria
Prior art keywords
pneumococces
modulation
production
test compound
capsule polysaccharides
Prior art date
Application number
AT01918754T
Other languages
English (en)
Inventor
Jeffrey Weiser
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE437955(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Application granted granted Critical
Publication of ATE437955T1 publication Critical patent/ATE437955T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT01918754T 2000-03-16 2001-03-16 Modulation der produktion von kapsel- polysacchariden aus pneumokokken ATE437955T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
PCT/US2001/008442 WO2001068903A1 (en) 2000-03-16 2001-03-16 Modulating production of pneumococcal capsular polysaccharide

Publications (1)

Publication Number Publication Date
ATE437955T1 true ATE437955T1 (de) 2009-08-15

Family

ID=22699002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918754T ATE437955T1 (de) 2000-03-16 2001-03-16 Modulation der produktion von kapsel- polysacchariden aus pneumokokken

Country Status (19)

Country Link
US (1) US6642017B2 (de)
EP (2) EP1967591A3 (de)
JP (1) JP4856345B2 (de)
KR (3) KR100942738B1 (de)
CN (2) CN101586143A (de)
AT (1) ATE437955T1 (de)
AU (2) AU2001245795B2 (de)
BR (1) BRPI0109293B8 (de)
CA (1) CA2403001C (de)
CY (1) CY1109418T1 (de)
DE (1) DE60139384D1 (de)
DK (1) DK1268844T3 (de)
ES (1) ES2330919T3 (de)
HK (1) HK1055448A1 (de)
IL (3) IL151772A0 (de)
MX (1) MXPA02009047A (de)
NZ (1) NZ521343A (de)
PT (1) PT1268844E (de)
WO (1) WO2001068903A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403001C (en) * 2000-03-16 2012-07-03 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
BRPI0607026B1 (pt) * 2005-04-08 2022-02-15 Wyeth Processos para redução do teor de proteína e preservação do teor de polissacarídeo capsular em um caldo de lisado celular de streptococcus pneumoniae complexo antes da purificação
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
BR122019021950B8 (pt) * 2006-10-10 2021-07-27 Wyeth Corp métodos para a redução ou remoção de impurezas protéicas de um lisado ou centrado celular de streptococcus pneumoniae compreendendo polissacarídeos sorotipo 3
WO2009059054A2 (en) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Bacteria strains an d bacteriocin produced therefrom
KR101307703B1 (ko) * 2008-12-18 2013-09-11 와이어쓰 엘엘씨 탄소를 사용하여 스트렙토코커스 뉴모니에 폴리사카라이드 분자량을 조절하는 방법
KR101593770B1 (ko) * 2008-12-18 2016-02-15 와이어쓰 엘엘씨 스트렙토코커스 뉴모니에 혈청형 19ａ 폴리사카라이드 분자량을 조절하는 방법
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
US9776905B2 (en) 2014-07-31 2017-10-03 Corning Incorporated Highly strengthened glass article
ES2933027T3 (es) 2014-05-07 2023-01-31 Glaxosmithkline Biologicals Sa Purificación de polisacáridos secretados de S. agalactiae
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
JP6923555B2 (ja) 2016-01-12 2021-08-18 コーニング インコーポレイテッド 薄厚熱強化及び化学強化ガラス系物品
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
CN111065609A (zh) 2017-08-24 2020-04-24 康宁股份有限公司 具有改进的回火能力的玻璃
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
CN111630153A (zh) * 2018-01-22 2020-09-04 一般财团法人阪大微生物病研究会 用于培养肺炎球菌样品的培养基
WO2021025981A1 (en) 2019-08-06 2021-02-11 Corning Incorporated Glass laminate with buried stress spikes to arrest cracks and methods of making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
WO1995031548A1 (en) * 1994-05-16 1995-11-23 The Uab Research Foundation Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
CA2403001C (en) * 2000-03-16 2012-07-03 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide

Also Published As

Publication number Publication date
IL151772A (en) 2009-12-24
EP1268844A4 (de) 2006-03-29
JP4856345B2 (ja) 2012-01-18
KR100942738B1 (ko) 2010-02-17
DK1268844T3 (da) 2009-11-16
ES2330919T3 (es) 2009-12-17
US20030021811A1 (en) 2003-01-30
BR0109293A (pt) 2003-06-10
CN101586143A (zh) 2009-11-25
BRPI0109293B8 (pt) 2021-05-25
DE60139384D1 (de) 2009-09-10
IL191962A (en) 2010-12-30
AU4579501A (en) 2001-09-24
CN1429276A (zh) 2003-07-09
US6642017B2 (en) 2003-11-04
WO2001068903A1 (en) 2001-09-20
NZ521343A (en) 2005-03-24
KR100914702B1 (ko) 2009-08-28
CY1109418T1 (el) 2014-08-13
KR20080036656A (ko) 2008-04-28
HK1055448A1 (en) 2004-01-09
CA2403001C (en) 2012-07-03
JP2003531584A (ja) 2003-10-28
EP1967591A2 (de) 2008-09-10
KR20030040196A (ko) 2003-05-22
IL191962A0 (en) 2008-12-29
EP1268844A1 (de) 2003-01-02
CA2403001A1 (en) 2001-09-20
KR20080081978A (ko) 2008-09-10
PT1268844E (pt) 2009-11-03
IL151772A0 (en) 2003-04-10
BRPI0109293B1 (pt) 2015-05-19
MXPA02009047A (es) 2005-04-19
EP1967591A3 (de) 2008-12-03
EP1268844B1 (de) 2009-07-29
AU2001245795B2 (en) 2005-07-28
CN100529054C (zh) 2009-08-19

Similar Documents

Publication Publication Date Title
DE60139384D1 (de) Modulation der produktion von kapsel-polysacchariden aus pneumokokken
TR200000060T2 (tr) Bir N-fenil-2-pirimidinamin türevinin kristal modifikasyonu ve yapım işlemleri ve kullanımı.
EA200000457A1 (ru) Способ и система для обнаружения аналита
NO20015096D0 (no) Måling og bruk av molekul¶re interaksjoner
NO304098B1 (no) Injeksjonsoppl°sning og injeksjonssett inneholdende 2-[(2-pyridyl)metylsulfinyl]benzimidazolforbindelse
TR200003632T2 (tr) Benzotiyepin-1,1-dioksid türevleri, üretim yöntemi, bunları içeren ilaçlar.
ATE390629T1 (de) Mikrophysiomessgerät
DE60123868D1 (de) Steckverbinder für Kassette von elektronischen Teilen
ATE71111T1 (de) Peptid-derivate, renin- und saeureprotease hemmende mittel.
BR0108240A (pt) Desidroaminoácidos
NO880542D0 (no) Zirkoniumchelater og fremstilling og anvendelse av disse.
HUP0303144A2 (hu) Eljárások szubsztituált 2-(2-piridil-metil)-szulfinil-1H-benzimidazolok előállítására
ATE314631T1 (de) Thermometer
ATE287403T1 (de) 6-phenylbenzonaphthyidine
DE3775872D1 (de) Salicylsaeureamide, verfahren zu ihrer herstellung und ihre verwendung.
DE68929371D1 (de) Verstärker mit grosser verstärkung für integrierte schaltungen
DE68914832D1 (de) Abtast-/halteverstärker für integrierte schaltungen.
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
DE60103061D1 (de) Verfahren zur identifizierung von verbindungen, die den anaphase-fördernden komplex hemmen
ATE198208T1 (de) Aus imidazo-(1,5a)-pyridin stammende inhibitoren von serinproteasen
DE3774947D1 (de) Alpha-acylamino-aminoalkyl-phosphonat-inhibitor des angiotensin umwandelnden enzyms.
RU97111970A (ru) Способ контроля состояния пульсирующего термального источника или скважины
NO900799L (no) Fremgangsmaate for fremstilling av inhibitorer for angiotensinomdannende enzym.
BR0101556A (pt) Composto heterocìclico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1268844

Country of ref document: EP